$18.69
0.945.30%
At close: Jun 12, 5:00 PM EST
$18.65
-0.04-0.21%
After Hours: Jun 12, 6:40 PM EST
MoonLake Immunotherapeutics Earnings Estimates
MLTXNASDAQ
MoonLake Earnings Estimates, EPS & Revenue | NASDAQ:MLTX
MoonLake (MLTX) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-0.92 and quarterly revenue of N/A.
In the most recent quarter (Q1), MoonLake reported EPS of $-0.98, missing estimates of $-0.90 by 0.09%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, MoonLake has averaged an EPS surprise of 0.13% and a revenue surprise of 0.00%.
Earnings Date
Aug 4
EPS Estimate
$-0.920
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
MoonLake Earnings History
Analyze the earnings history of MoonLake using advanced sorting and filters.
Loading calendar...
MoonLake (MLTX) Earnings Per Share
The chart below shows MoonLake's reported EPS compared to analyst estimates over recent quarters.
MoonLake (MLTX) Revenue
The chart below shows MoonLake's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is MoonLake (NASDAQ:MLTX) reporting earnings?
MoonLake (MLTX) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 11, 2026 for Q1.
What were the latest earnings per share (EPS) for MoonLake (NASDAQ:MLTX)?
The Actual EPS was $-0.98, which missed the estimate of $-0.90.
What were MoonLake’s (NASDAQ:MLTX) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
